Resistin levels in patients with obstructive sleep apnoea syndrome - The link to subclinical inflammation?

Medical Science Monitor

Volumn 10, Issue 9, 2004, Pages

  Harsch, Igor Alexander ^a   Koebnick, Corinna ^b   Wallaschofski, Henri ^a   Schahin, Simin Pour ^a   Hahn, Eckhart Georg ^a   Ficker, Joachim Hans ^c   Lohmann, Tobias ^d   Konturek, Peter Christopher ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c Klinikum Starnberg   (Germany)

^d UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

ICAM 1; Insulin sensitivity; Interleukinin 6; Obstructive sleep apnea syndrome; Resistin

Indexed keywords

AUTACOID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; RESISTIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE CLAMP TECHNIQUE; HORMONE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN SENSITIVITY; OBESITY; PARAMETER; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PROTEIN BLOOD LEVEL; SLEEP APNEA SYNDROME; WHITE ADIPOSE TISSUE;

BODY MASS INDEX; C-REACTIVE PROTEIN; CONTINUOUS POSITIVE AIRWAY PRESSURE; HORMONES, ECTOPIC; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; LEPTIN; MIDDLE AGED; OBESITY; PATIENT COMPLIANCE; POLYSOMNOGRAPHY; RESISTIN; SLEEP APNEA, OBSTRUCTIVE; STATISTICS;

EID: 4644285153     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Hill OJ, Wyatt HR, Reed GW, Peters JC: Obesity and the environment: where do we go from here? Science, 2003; 299: 853-55
2. Zhang Y, Proenca R, Maffei M et al: Positional cloning of the mouse obese gene and its human homologue. Nature, 1994: 372: 425-32
3. Maeda K, Okubo K, Shimomura I et al: cDNA cloning and expression of a new adipose-specific collagen-like factor, apM1 (AdiPose Most Abundant Gene Transcript 1). Biochem Bipohys Res Commun, 1996; 221: 286-89
4. Scherer PE, Williams S, Fogliano M et al: A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem, 1995; 270: 26746-49
5. Hu E, Liang P, Spiegelman BM: AdipoQ is a novel adipose-specific gene deregulated in obesity. J Biol Chem, 1996; 271: 10697-703
6. Nakano Y, Tobe T, Choi-Miura NH et al: Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma, J Biochem, 1996; 120: 803-12
7. Steppan CM, Bailey ST, Bhat S et al: The hormone resistin links obesity to diabetes. Nature, 2001; 409: 307-12
8. Piatti P, Di Mario C, Monti LD et al: Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting. Circulation, 2003; 108: 2074-78
9. Iatagai T, Nagasaka S, Taniguchi A et al: Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in japanese men with type 2 diabetes mellitus. Metabolism, 2003; 52: 1274-78
10. Wagenknecht LE, Langefeld CD, Scherzinger AL et al: Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes, 2003; 52: 2490-96
11. Bannerjee RR. Lazar MA: Dimerization of resistin and resistin-like molecules is determined by a single cysteine. J Biol Chem, 2001; 276: 25970-73
12. Beltowski J: Adiponectin and resistin - new hormones of white adipose tissue. Med Sci Monit, 2003; 9: RA55-RA61
13. Gomez-Ambrosi J, Frūhbeck G: Do resistin and resistin-like molecules also link obesity to inflammatory diseases? Ann Intern Med, 2001; 135: 306-7
14. Savage DB, Sewter CK, Klenk ES et al: Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes, 2001; 50: 2199-202
15. Janke J, Engeli S, Gorzelniak K et al: Resistin gene expression in human adipocytes is not related to insulin resistance. Obes Res, 2002; 10:1-5
16. Harsch IA, Pour Schahin S, Radespiel-Tröger M et al: Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med, 2004; 169: 156-62
17. Ip MS, Lam B, Ng MMT et al: Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med, 2002; 165: 670-76
18. Sullivan CE, Issa FG, Berthon-Jones M, Eves L: Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet, 1981; I: 862-65
19. Penzel T, Hajak G, Hoffmann RM et al: Empfehlungen zur Durchführung und Auswertung polygrafischer Ableitungen im diagnostischen Schlaflabor. EEG-EMG, 1993; 24: 65-70
20. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol, 1979; 237: E214-E223
21. American Thoracic Society: Indications and standards for use of nasal continuous airway pressure (CPAP) in sleep apnea syndromes. Am J Respir Crit Care Med, 1994; 150: 1738-45
22. Rechtschaffen A, Kahles A: A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Public Health Service, US Government Printing Office, Los Angeles, 1968
23. Bonnet M, Charley D, Carskadon MA: EEG arousals: scoring rules and examples. Sleep, 1992; 15: 174-84
24. Lee JH, Chan JL, Yiannakouris N et al: Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: Cross-sectional and interventional studies in normal, insulin resistant and diabetic subjects. J Clin Endocrinol Metab, 2003; 88: 4848-56
25. Yannakoula M, Yiannakouris N, Blühr S et al: Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin and resistin concentrations in healthy humans.. J Clin Endocrinol Metab, 2003; 88: 1730-36
26. Hak AE, Pols HA, Stehouwer CD et al: Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. J Clin Endocrinol Metab, 2001, 86: 4398-405
27. Pearson TA, Mensah GA, Alexander RW et al: Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 2003, 28: 499-511
28. Ridker PM, Rifaj N, Rose L et al: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med, 2002; 347: 1557-65
29. Rattazzi M, Puato M, Faggin E et al: C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders? J Hypertens, 2003; 21: 1787-803
30. Yokoe T, Minoguchi K, Matsuo H et al: Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation, 2003; 107: 1129-34
31. Beltowski J, Wojcicka G, Gorny D, Marciniak A: The effect of diet-induced obesity on lipid peroxidation, antioxidant enzymes and total plasma antioxidant capacity. J Physiol Pharmacol, 2000; 51: 883-96
32. Geiser T, Buck F, Meyer BJ et al: In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration, 2002; 69: 229-34
33. Ohga E, Tomita T, Wada H et al: Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol, 2003, 94: 179-84
34. Oguogho A, Sinzinger H: Isoprostanes and atherosclerosis. J Physiol Pharmacol, 2000; 51: 673-82
35. Ridker PM, Hennekens CH, Roitman-Johnson B et al: Plasma concentration of soluble intercellular adhesion molecule I and risks of future myocardial infarction in apparently healthy men. Lancet, 1998; 351: 88-92
36. Verma S, Li S-H, Wang C-H et al: Resistin promotes endothelial cell activation. Further evidence of adipokine-endothelial interaction. Circulation, 2003; 108: 736-40
37. Blüher M, Unger R, Rassoul F et al: Relation between glycaemic control, hyperinsulinemia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose tolerance or type II diabetes. Diabetologia, 2002; 45: 210-16
38. Punjabi NM, Sorkin JD, Karzel LI et al: Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Grit Care Med, 2002; 165: 677-82